149 related articles for article (PubMed ID: 30266136)
1. Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Soudy R; Tikoo R; Kaur K; Verrall RE; Badea I
J Pharm Pharm Sci; 2018; 21(1):363-375. PubMed ID: 30266136
[TBL] [Abstract][Full Text] [Related]
2. Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Chitanda J; Al-Dulaymi M; Verrall R; Badea I
Pharm Res; 2017 Sep; 34(9):1886-1896. PubMed ID: 28643235
[TBL] [Abstract][Full Text] [Related]
3. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
[TBL] [Abstract][Full Text] [Related]
4. Peptide-Modified Gemini Surfactants: Preparation and Characterization for Gene Delivery.
Al-Dulaymi M; Mohammed-Saeid W; El-Aneed A; Badea I
Methods Mol Biol; 2019; 2000():203-225. PubMed ID: 31148017
[TBL] [Abstract][Full Text] [Related]
5. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
6. Modulation of pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on lipoplex transfection properties.
Sharma VD; Lees J; Hoffman NE; Brailoiu E; Madesh M; Wunder SL; Ilies MA
Mol Pharm; 2014 Feb; 11(2):545-59. PubMed ID: 24377350
[TBL] [Abstract][Full Text] [Related]
7. Transgene expression in mice of the Opa1 mitochondrial transmembrane protein through bicontinuous cubic lipoplexes containing gemini imidazolium surfactants.
Muñoz-Úbeda M; Semenzato M; Franco-Romero A; Junquera E; Aicart E; Scorrano L; López-Montero I
J Nanobiotechnology; 2021 Dec; 19(1):425. PubMed ID: 34922554
[TBL] [Abstract][Full Text] [Related]
8. Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity.
Al-Dulaymi MA; Chitanda JM; Mohammed-Saeid W; Araghi HY; Verrall RE; Grochulski P; Badea I
AAPS J; 2016 Sep; 18(5):1168-1181. PubMed ID: 27184577
[TBL] [Abstract][Full Text] [Related]
9. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
10. Improved in vitro gene transfer mediated by fluorinated lipoplexes in the presence of a bile salt surfactant.
Gaucheron J; Santaella C; Vierling P
J Gene Med; 2001; 3(4):338-44. PubMed ID: 11529663
[TBL] [Abstract][Full Text] [Related]
11. Peptide-mediated lipofection is governed by lipoplex physical properties and the density of surface-displayed amines.
Rea JC; Barron AE; Shea LD
J Pharm Sci; 2008 Nov; 97(11):4794-806. PubMed ID: 18306277
[TBL] [Abstract][Full Text] [Related]
12. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
Narsineni L; Foldvari M
Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
[TBL] [Abstract][Full Text] [Related]
13. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(3):289-306. PubMed ID: 26785905
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
[TBL] [Abstract][Full Text] [Related]
15. Molecular Engineering as an Approach To Modulate Gene Delivery Efficiency of Peptide-Modified Gemini Surfactants.
Al-Dulaymi M; Michel D; Chitanda JM; El-Aneed A; Verrall RE; Grochulski P; Badea I
Bioconjug Chem; 2018 Oct; 29(10):3293-3308. PubMed ID: 30169953
[TBL] [Abstract][Full Text] [Related]
16. Lipoplexes formed from sugar-based gemini surfactants undergo a lamellar-to-micellar phase transition at acidic pH. Evidence for a non-inverted membrane-destabilizing hexagonal phase of lipoplexes.
Wasungu L; Stuart MC; Scarzello M; Engberts JB; Hoekstra D
Biochim Biophys Acta; 2006 Oct; 1758(10):1677-84. PubMed ID: 16930530
[TBL] [Abstract][Full Text] [Related]
17. Transfection efficiencies of α-tocopherylated cationic gemini lipids with hydroxyethyl bearing headgroups under high serum conditions.
Maiti B; Kamra M; Karande AA; Bhattacharya S
Org Biomol Chem; 2018 Mar; 16(11):1983-1993. PubMed ID: 29498723
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models.
Michel D; Mohammed-Saeid W; Getson H; Roy C; Poorghorban M; Chitanda JM; Verrall R; Badea I
Int J Nanomedicine; 2016; 11():6703-6712. PubMed ID: 28003746
[TBL] [Abstract][Full Text] [Related]
19. Interactions between DNA and gemini surfactant: impact on gene therapy: part II.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(4):403-20. PubMed ID: 26784450
[TBL] [Abstract][Full Text] [Related]
20. Tunable pDNA/DODAB:MO lipoplexes: the effect of incubation temperature on pDNA/DODAB:MO lipoplexes structure and transfection efficiency.
Silva JP; Oliveira AC; Lúcio M; Gomes AC; Coutinho PJ; Oliveira ME
Colloids Surf B Biointerfaces; 2014 Sep; 121():371-9. PubMed ID: 25023903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
